James Felker: Clinical Trials

3 trials sponsored by James Felker, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Recruiting 1

Follow James Felker: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Vaccine Trial for Low Grade Gliomas
Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC - Low Grade Glioma
Phase 2RecruitingJames Felker252015-01-012026-01-07
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
HLA-A2 restricted synthetic tumor antigen, Imiquimod, enzyme-linked immunosorbent assay - Ependymoma
Phase 1TerminatedJames Felker232012-08-012026-02-05
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas
HLA-A2 restricted glioma antigen peptides vaccine, Poly-ICLC - Newly Diagnosed Pediatric Pontine Glioma, Newly Diagnosed Pediatric High Grade Glioma
Phase 1CompletedJames Felker602009-02-012024-12-06

Conditions studied

Ependymoma (1)

Interventions

poly ICLC (2)  ·  Enzyme-Linked Immunosorbent Assay (1)  ·  Flow Cytometry (1)  ·  Imiquimod (1)  ·  Immunohistochemistry (1)

Countries

United States (3)

Results publications

PMID 24792486, PMID 24888813

NIH funding

R01CA174858 (1), R01CA187219 (1)